Tender Offer - Kent Lake PR LLC

Form Type: DFAN14A

Filing Date: 2025-05-23

Corporate Action: Tender-offer

Type: New

Accession Number: 000153949725001517

Filing Summary: Kent Lake PR LLC, holding approximately 6.9% of Quanterix Corporation's outstanding common stock, has issued a statement regarding Quanterix's amended merger terms and Akoya Biosciences' unsolicited all-cash tender offer of $1.40-per-share. The proposal from Akoya is presented as a superior option, with a 22% premium over Akoya’s 30-day volume-weighted average price and Quanterix's implied offer under the amended merger agreement. Kent Lake argues that Quanterix needs to raise its cash consideration by an additional $20 million to match this superior proposal and criticizes the Quanterix board for avoiding shareholder approval during this renegotiation. The document reveals significant concerns about Quanterix's financial situations, stating that it trades at a material discount to its net cash position due to investor apprehension regarding potential value destruction resulting from the pursued merger. The statement highlights that the board’s decision could represent a breach of fiduciary duty if they continue with the Akoya deal contrary to shareholders' interests. Kent Lake is soliciting votes for its slate of director nominees at the upcoming annual meeting of Quanterix's stockholders.